paxilline has been researched along with Carcinoma, Ductal, Breast in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Athanassiadou, AM; Athanassiadou, P; Kyriakidou, V; Lagoudianakis, E; Manouras, A; Panousis, D; Pappas, A; Patsouris, E; Voulgaris, Z; Xepapadakis, G | 1 |
| Cocker, R; Fayyad, R; Madan, R; Oktay, MH; Smolkin, MB | 1 |
2 other study(ies) available for paxilline and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Immunohistochemistry; Middle Aged; Paxillin; Poly-ADP-Ribose Binding Proteins; Polycomb Repressive Complex 2; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Transcription Factors | 2011 |
Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
Topics: Biomarkers, Tumor; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Cell Transformation, Neoplastic; Female; Fibroadenoma; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunohistochemistry; Lymph Nodes; Paxillin; Prognosis; Protein Array Analysis; Proto-Oncogene Proteins pp60(c-src); Signal Transduction | 2006 |